<- Go Home
Athersys, Inc.
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine.
Market Cap
$61.00
Volume
405.8K
Cash and Equivalents
$1.0M
EBITDA
-$28.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$18.7M
Profit Margin
-23368.75%
52 Week High
$0.04
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
0.00
Price / Tangible Book Value
0.00
Enterprise Value
$17.6M
Enterprise Value / EBITDA
-0.69
Operating Income
-$28.7M
Return on Equity
141.51%
Return on Assets
-83.56
Cash and Short Term Investments
$1.0M
Debt
$18.6M
Equity
-$36.4M
Revenue
$80.0K
Unlevered FCF
-$25.1M
Sector
Biotechnology
Category
N/A